Stock DUL ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Alnylam Pharmaceuticals, Inc. Börse Stuttgart

Equities

DUL

US02043Q1076

Real-time Estimate Tradegate
Other stock markets
 11:44:40 2024-07-02 EDT 		5-day change 1st Jan Change
230.8 EUR +1.92% Intraday chart for Alnylam Pharmaceuticals, Inc. +7.70% +28.99%
06-28 UBS Adjusts Price Target on Alnylam Pharmaceuticals to $288 From $253, Maintains Buy Rating MT
06-27 Stifel Adjusts Price Target on Alnylam Pharmaceuticals to $295 From $215, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ALNYLAM PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
-0.66%+7.70% - - - 30.78B - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. DUL Stock
  5. Charts Alnylam Pharmaceuticals, Inc.
  6. Comparison Chart